NIOX Group PLC (LON:NIOX)
57.00p-2.40%
Spriggl Score: Good— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Near-monopoly asthma-testing franchise delivers 39% cash conversion; premium valuation demands sustained growth execution.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, se…
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market Cap:
- £249.1M
Recent dividends
- 21 May 20261.55p
- 15 May 20251.25p
- 23 May 20241.00p
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on NIOX Group PLC and 1,600+ UK and US stocks.
Start free